Nasal Polyps Treatment Market

Nasal Polyps Treatment Market (Type of Treatment: Pharmacological Therapies (Corticosteroids, Antibiotics, Leukotriene Inhibitors, Others), and Surgeries (Polypectomy, Functional Endoscopic Sinus Surgery (FESS)); End User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Rep Id : TMRGL53529
  • Published On : Aug 2019
  • No. of Pages : 168
  • Category : Healthcare

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Polyps Treatment Market
4. Market Overview

    4.1. Introduction
        4.1.1. Treatment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017–2027
        4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
    5.1. Key Industry Developments
    5.2. Pipeline Analysis
    5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents
        5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala) 
6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment 
    6.1. Introduction & Definition
    6.2. Market Value Forecast, by Type of Treatment , 2017–2027
        6.2.1. Pharmacological Therapies
            6.2.1.1. Corticosteroids 
            6.2.1.2. Antibiotics 
            6.2.1.3. Leukotriene Inhibitors 
            6.2.1.4. Others
        6.2.2. Surgeries
            6.2.2.1. Polypectomy 
            6.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    6.3. Market Attractiveness By Type of Treatment 
7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user 
    7.1. Introduction & Definition
    7.2. Market Value Forecast, by End-user, 2017–2027
        7.2.1. Hospitals 
        7.2.2. Ambulatory Surgical Centers 
        7.2.3. Specialty Clinics 
    7.3. Market Attractiveness, by End-user 
8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
    8.1. Introduction
    8.2. Market Value Forecast, by Region
        8.2.1. North America 
        8.2.2. Europe 
        8.2.3. Asia Pacific 
        8.2.4. Latin America 
        8.2.5. Middle East & Africa 
    8.3. Market Attractiveness, by Country/Region
9. North America Nasal Polyps Treatment Market Analysis and Forecast
    9.1. Introduction
    9.2. Market Value Forecast, by Type of Treatment , 2017–2027
        9.2.1. Pharmacological Therapies
            9.2.1.1. Corticosteroids 
            9.2.1.2. Antibiotics 
            9.2.1.3. Leukotriene Inhibitors 
            9.2.1.4. Others
        9.2.2. Surgeries
            9.2.2.1. Polypectomy 
            9.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    9.3. Market Value Forecast, by End-user, 2017–2027
        9.3.1. Hospitals 
        9.3.2. Ambulatory Surgical Centers 
        9.3.3. Specialty Clinics 
    9.4. Market Value Forecast, by Country, 2017–2027
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis 
        9.5.1. By Type of Treatment 
        9.5.2. By End-user 
        9.5.3. By Country
10. Europe Nasal Polyps Treatment Market Analysis and Forecast
    10.1. Introduction
    10.2. Market Value Forecast, by Type of Treatment , 2017–2027
        10.2.1. Pharmacological Therapies
            10.2.1.1. Corticosteroids 
            10.2.1.2. Antibiotics 
            10.2.1.3. Leukotriene Inhibitors 
            10.2.1.4. Others
        10.2.2. Surgeries
            10.2.2.1. Polypectomy 
            10.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    10.3. Market Value Forecast, by End-user, 2017–2027
        10.3.1. Hospitals 
        10.3.2. Ambulatory Surgical Centers 
        10.3.3. Specialty Clinics 
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis 
        10.5.1. By Type of Treatment 
        10.5.2. By End-user 
        10.5.3. By Country/Sub-region
11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
    11.1. Introduction
    11.2. Market Value Forecast, by Type of Treatment, 2017–2027
        11.2.1. Pharmacological Therapies
            11.2.1.1. Corticosteroids 
            11.2.1.2. Antibiotics 
            11.2.1.3. Leukotriene Inhibitors 
            11.2.1.4. Others
        11.2.2. Surgeries
            11.2.2.1. Polypectomy 
            11.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    11.3. Market Value Forecast, by End-user, 2017–2027
        11.3.1. Hospitals 
        11.3.2. Ambulatory Surgical Centers 
        11.3.3. Specialty Clinics 
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis 
        11.5.1. By Type of Treatment 
        11.5.2. By End-user 
        11.5.3. By Country/Sub-region
12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
    12.1. Introduction
    12.2. Market Value Forecast, by Type of Treatment, 2017–2027
        12.2.1. Pharmacological Therapies
            12.2.1.1. Corticosteroids 
            12.2.1.2. Antibiotics 
            12.2.1.3. Leukotriene Inhibitors 
            12.2.1.4. Others
        12.2.2. Surgeries
            12.2.2.1. Polypectomy 
            12.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    12.3. Market Value Forecast, by End-user, 2017–2027
        12.3.1. Hospitals 
        12.3.2. Ambulatory Surgical Centers 
        12.3.3. Specialty Clinics 
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis 
        12.5.1. By Type of Treatment 
        12.5.2. By End-user 
        12.5.3. By Country/Sub-region
13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
    13.1. Introduction
    13.2. Market Value Forecast, by Type of Treatment , 2017–2027
        13.2.1. Pharmacological Therapies
            13.2.1.1. Corticosteroids 
            13.2.1.2. Antibiotics 
            13.2.1.3. Leukotriene Inhibitors 
            13.2.1.4. Others
        13.2.2. Surgery 
            13.2.2.1. Polypectomy 
            13.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
    13.3. Market Value Forecast, by End-user, 2017–2027
        13.3.1. Hospitals 
        13.3.2. Ambulatory Surgical Centers 
        13.3.3. Specialty Clinics 
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis 
        13.5.1. By Type of Treatment 
        13.5.2. By End-user 
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player - Competition Matrix (By Tier and Size of companies)
    14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018
    14.3. Company Profiles
        14.3.1. OptiNose US, Inc.
        14.3.2. Regeneron Pharmaceuticals, Inc.
        14.3.3. Merck & Co., Inc.
        14.3.4. Pfizer, Inc.
        14.3.5. F. Hoffmann La-Roche, Ltd. 
        14.3.6. Intersect ENT, Inc.
        14.3.7. GlaxoSmithKline plc 
        14.3.8. Sanofi
        14.3.9. Novartis AG

List of Tables

Table 01: Pipeline Analysis: Nasal Polyps
Table 02: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 04: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 05: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 09: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 10: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 11: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 12: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 14: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 15: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 16: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 17: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 19: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 20: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 21: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 22: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 24: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 25: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 26: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 27: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 29: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 30: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 31: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027

List of Figures

Figure 01: Global Nasal Polyps Treatment Market Snapshot
Figure 02: Global Nasal Polyps Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 04: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018
Figure 05: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018
Figure 06: Global Nasal Polyps Treatment Market Value Share (%), by Region, 2018
Figure 07: Nasal Polyps Treatment Market - Collaborations, Partnerships & New Product Launch 
Figure 08: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 09: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacological Therapies, 2017–2027
Figure 10: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgeries, 2017–2027
Figure 11: Global Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 12: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 13: Global Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 14: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 15: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 16: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 17: Global Nasal Polyps Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 18: Global Nasal Polyps Treatment Market Attractiveness Analysis, by Region, 2019–2027
Figure 19: North America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 20: North America Nasal Polyps Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 21: North America Nasal Polyps Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 22: North America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 23: North America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 24: North America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 25: North America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 26: Europe Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 27: Europe Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 28: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 29: Europe Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 30: Europe Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 31: Europe Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 32: Europe Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 33: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 35: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 36: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 37: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 38: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 39: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 40: Latin America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 41: Latin America Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Latin America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 44: Latin America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 45: Latin America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 46: Latin America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 47: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 48: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 49: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 50: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 51: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 52: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 53: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 54: Global Nasal Polyps Treatment Market Position Analysis, by Top Company Ranking, 2018
Figure 55: OptiNose US, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 56: OptiNose US, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 57: Regeneron Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 58: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 59: Regeneron Pharmaceuticals Inc., Breakdown of Net Sales (%), by Product, 2018
Figure 60: Merck & Co., Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 62: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 63: Merck & Co., Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 64: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 65: Pfizer, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 66: Pfizer, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 67: Pfizer, Inc., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 68: F. Hoffmann-La Roche, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 70: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Region, 2018
Figure 71: F. Hoffmann-La Roche, Ltd., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 72: Intersect ENT, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Intersect ENT, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: GlaxoSmithKline plc, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 75: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Geography, 2018
Figure 77: GlaxoSmithKline plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 78: Sanofi, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 79: Sanofi, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 80: Sanofi, Breakdown of Net Sales (%), by Geography, 2018
Figure 81: Sanofi, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 82: Novartis AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 83: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 84: Novartis AG, Breakdown of Net Sales (%), by Region, 2018
Figure 85: Novartis AG, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

.